Dr Huah Shin Ng

Dr Huah Shin Ng

School of Allied Health and Human Performance

College of Health

Dr. Huah Shin Ng is currently an Adjunct Researcher at UniSA and a Practitioner Fellow at Flinders University. She is also a pharmacist with experiences working in both hospital and community settings. Her current research focuses on cancer survivorship and cancer pharmacoepidemiology.
Huah Shin has recently completed her postdoctoral research training at the University of British Columbia, Canada (2019-21) with her research focused on the assessment of the real-world safety profiles and effectiveness of disease-modifying drugs in the multiple sclerosis population (funded by the Multiple Sclerosis Society of Canada’s endMS Post-Doctoral Fellowship, the Michael Smith Foundation for Health Reserach Trainee Award and the Canadian Institutes of Health Research Drug Safety and Effectiveness Cross-Disciplinary Training Program).
Her research interests include pharmacoepidemiology, medication safety and effectiveness, and chronic diseases (cancer and multiple sclerosis).

Year Citation
2025 Ng, H. S., Johansen, C., Li, M., Roder, D., Beckmann, K., & Koczwara, B. (2025). Patterns of medication use following breast cancer diagnosis: an Australian population-based study.. Supportive Care in Cancer, 33(8, article no. 668), 1-11.
DOI Scopus1
2025 Lim, A. Y. L., Perkins, C. J., Bakoos, D., Joud, N., Rahimi, A. S., Thomas, V., . . . Ng, H. S. (2025). Provision of on-call pharmacist services across public hospitals: a retrospective observational study. INTERNATIONAL JOURNAL OF PHARMACY PRACTICE, 34(1), 8 pages.
DOI
2020 Ng, H. S., Koczwara, B., Roder, D., Chan, R. J., & Vitry, A. (2020). Patterns of health service utilisation among the Australian population with cancer compared with the general population. Australian Health Review, 44(3), 470-479.
DOI Scopus11 WoS10 Europe PMC6
2019 Ng, H. S., Vitry, A., Koczwara, B., Roder, D., & McBride, M. L. (2019). Patterns of comorbidities in women with breast cancer: a Canadian population-based study. Cancer causes & control, 30(9), 931-941.
DOI Scopus49 WoS48 Europe PMC46
2018 Ng, H. S., Roder, D., Koczwara, B., & Vitry, A. (2018). Comorbidity, physical and mental health among cancer patients and survivors: An Australian population-based study.. Asia-Pacific journal of clinical oncology, 14(2), e181-e192.
DOI Scopus62 WoS55 Europe PMC51
2018 Ng, H. S., Koczwara, B., Roder, D. M., Niyonsenga, T., & Vitry, A. I. (2018). Comorbidities in Australian women with hormone-dependent breast cancer: a population-based analysis. Medical Journal of Australia, 208(1), 24-28.
DOI Scopus21 WoS20 Europe PMC19
2018 Ng, H. S., Koczwara, B., Roder, D., & Vitry, A. (2018). Changes in the prevalence of comorbidity in the Australian population with cancer, 2007-2014. Cancer epidemiology, 54, 56-62.
DOI Scopus13 WoS13 Europe PMC9
2018 Ng, H. S., Koczwara, B., Roder, D., Niyonsenga, T., & Vitry, A. (2018). Incidence of comorbidities in women with breast cancer treated with tamoxifen or an aromatase inhibitor: an Australian population-based cohort study. Journal of comorbidity, 8(1), 16-24.
DOI Europe PMC15
2018 Ng, H. S., Koczwara, B., Roder, D., & Vitry, A. (2018). Development of comorbidities in men with prostate cancer treated with androgen deprivation therapy: an Australian population-based cohort study. Prostate cancer and prostatic diseases, 21(3), 403-410.
DOI Scopus50 WoS49 Europe PMC42
2013 Vitry, A. I., Ng, H. S., & Vitre, P. (2013). Assessment of the therapeutic value of new medicines marketed in Australia. Journal of pharmaceutical policy and practice, 6(article no. 2), 2.
DOI Scopus12 Europe PMC9

Connect With Me

Other Links